Tag: Spectral AI

Double Bubbler Portfolio Allocation (31st January 2026)

In case anyone is curious this chart shows the current approximate split of our ‘more adventurous’ capital allocated to Double Bubbler investments. This was based on closing market prices and…

Spectral AI: Zacks maintains $5 valuation and expects mid-2026 FDA decision

https://scr.zacks.com/news/news-details/2026/MDAI-In-the-Blocks-Ready-to-Go-upon-Mid-Year-Authorization-article/default.aspx The principle new information here for me is greater clarity on average FDA timescales for a decision on Spectral AI’s DeepView system. Notably ‘Based on historical data, a De…

Back To Top